Omeprazole Sandoz

Omeprazole, the active ingredient in Omeprazole Sandoz, is a proton pump inhibitor presented as an intravenous formulation for hospital use. It reduces gastric acid secretion and is used to treat conditions such as gastro‑oesophageal reflux disease, erosive esophagitis, peptic ulcer disease, and to prevent NSAID‑induced ulcers.

GNH USA supplies Omeprazole Sandoz as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals worldwide.

Omeprazole Sandoz is a proton pump inhibitor used to manage acid‑related gastrointestinal disorders.

- Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief by decreasing gastric acid exposure to the esophagus. - Erosive esophagitis: promotes healing of acid‑induced esophageal lesions. - Peptic ulcer disease: supports ulcer healing and reduces recurrence risk. - Prevention of NSAID‑induced ulcers: protects the gastric mucosa in patients receiving non‑steroidal anti‑inflammatory drugs.

Adverse reactions may occur with any medication, and patients should be monitored for both common and serious events.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually transient. - Nausea: may occur after infusion. - Abdominal pain: mild discomfort in the upper abdomen.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis requiring medical attention. - Severe allergic reaction (anaphylaxis): rapid onset of rash, swelling, and respiratory difficulty. - Hypomagnesemia: low serum magnesium with prolonged use. - Liver enzyme elevation: increased ALT/AST levels. - Stevens‑Johnson syndrome: rare but life‑threatening skin reaction.

Before initiating therapy, clinicians should consider several safety aspects.

- Assess renal function: adjust therapy in patients with severe renal impairment. - Monitor magnesium levels: prolonged treatment may lead to hypomagnesemia. - Use cautiously in hepatic disease: omeprazole is metabolised by the liver. - Avoid in known hypersensitivity: discontinue if allergic reactions occur. - Store at ambient temperature: keep in the original container, protect from moisture and light.

Omeprazole Sandoz can affect the pharmacokinetics of several co‑administered drugs.

Major Interactions (Avoid): - Clopidogrel: reduced antiplatelet effect, increasing cardiovascular risk. - Atazanavir: decreased absorption, compromising antiviral efficacy.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR, requiring closer coagulation monitoring. - Methotrexate: elevated serum levels, especially at high doses. - Digoxin: may increase serum digoxin concentrations, necessitating dose adjustment.